patients receiving ADMs saw noticeable spikes in the rate of discontinuation due to medication availability in January 2023 (5.3%) and June 2024 (4.8%), while patients receiving AOMs experienced higher rates of discontinuation due to medication availability throughout 2023 and into early 2024
Roenneberg T, Wirz-Justice A, Merrow M
Cloning and characterization of a theta class glutathione transferase from the potato pathogen Phytophthora infestans
Other investigators, like Lorenzo Leggio at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), have been looking at the potential to use a GLP-1 drugs to reduce the misuse of other addictive substances, such as alcohol, for a number of years
Kidneys: Improves kidney function, reduces anemia risks, and prevents aspartame-related kidney diseases